2 results
Approved WMOCompleted
The primary objective is:* To determine the overall response rate (ORR) of 4 weekly infusions of obinutuzumab monotherapy (Induction I) in patients with rituximab-refractory follicular lymphoma.The secondary objectives are:* To determine theā¦
Approved WMORecruiting
The primary objectives of this study are to confirm the clinic al safety and effectiveness of the Aveir LP system in subjects who are indicated for VVI(R) pacemaker.